Correlation Between Nurix Therapeutics and BeiGene

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Nurix Therapeutics and BeiGene at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nurix Therapeutics and BeiGene into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nurix Therapeutics and BeiGene, you can compare the effects of market volatilities on Nurix Therapeutics and BeiGene and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nurix Therapeutics with a short position of BeiGene. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nurix Therapeutics and BeiGene.

Diversification Opportunities for Nurix Therapeutics and BeiGene

-0.25
  Correlation Coefficient

Very good diversification

The 3 months correlation between Nurix and BeiGene is -0.25. Overlapping area represents the amount of risk that can be diversified away by holding Nurix Therapeutics and BeiGene in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BeiGene and Nurix Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nurix Therapeutics are associated (or correlated) with BeiGene. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BeiGene has no effect on the direction of Nurix Therapeutics i.e., Nurix Therapeutics and BeiGene go up and down completely randomly.

Pair Corralation between Nurix Therapeutics and BeiGene

Given the investment horizon of 90 days Nurix Therapeutics is expected to generate 1.64 times more return on investment than BeiGene. However, Nurix Therapeutics is 1.64 times more volatile than BeiGene. It trades about 0.07 of its potential returns per unit of risk. BeiGene is currently generating about 0.01 per unit of risk. If you would invest  1,014  in Nurix Therapeutics on September 1, 2024 and sell it today you would earn a total of  1,197  from holding Nurix Therapeutics or generate 118.05% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Nurix Therapeutics  vs.  BeiGene

 Performance 
       Timeline  
Nurix Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Nurix Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's forward indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
BeiGene 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in BeiGene are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady basic indicators, BeiGene exhibited solid returns over the last few months and may actually be approaching a breakup point.

Nurix Therapeutics and BeiGene Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Nurix Therapeutics and BeiGene

The main advantage of trading using opposite Nurix Therapeutics and BeiGene positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nurix Therapeutics position performs unexpectedly, BeiGene can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BeiGene will offset losses from the drop in BeiGene's long position.
The idea behind Nurix Therapeutics and BeiGene pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Other Complementary Tools

Share Portfolio
Track or share privately all of your investments from the convenience of any device
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings